Article
Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests.
Antimicrobial agents and chemotherapy - 1 Oct 2018
Kandler Justin L, Mercante Alexandra D, Dalton Tracy L, Ezewudo Matthew N, Cowan Lauren S, Burns Scott P, Metchock Beverly, Cegielski Peter, Posey James E
Abstract excerpt
Resistance to the first-line antituberculosis (TB) drug isoniazid (INH) is widespread, and the mechanism of resistance is unknown in approximately 15% of INH-resistant (INH-R) strains. To improve molecular detection of INH-R TB, we used whole-genome sequencing (WGS) to analyze 52 phenotypically INH-R Mycobacterium tuberculosis complex (MTBC) clinical isolates that lacked the common katG S315T or inhA promoter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
